|
| Catalog ID | Percent of Cells
with Chromosome | Cytogenetic Description | Additional Information |
| GM07298 | 100 | t(X;11)(Xqter>Xcen::11cen>11qter) (96%) & other human chromosomes | Line #2.12; human/HPRT-deficient Chinese hamster lung cell line; selected in medium containing azaserine; retains human chromosomes #4 (28%), #14 (92%), #20 (12%), #21 (64%), & t(X;11)(Xqter>cen> 11qter) in 100% of cells |
| GM09191 | 100 | der(6)t(X;6)(q13p21) (100%) | Line MCP-6; produced by fusing mouse teratocarcinoma line PCC4-1 with human Burkitt lymphoma line G3.32.2; selected in HAT medium; retains 1 hum chromo consistent with der(6)t(X;6)(Xqter>Xq13:: 6p21>6qter) reported by the submitter |
| GM10664 | 100 | der(15)t(X;15)(q25 or 26;q25) (100%), del(10)(10q11q25) (100%) & 22 (100%) | Line 94-3; produced by the PEG fusion of lymphoblasts from a pt with a t(X;15) (q25 or q26;q25) & the HPRT-def Chinese hamster cell line RJK88; selected in HZ medium; retains the human der(15) & human chromosome #22 in 100% of cells |
| GM11022 | 100 | der(X)t(X;2)(p21.2;q37) (100%) & other human chromosomes | Line 5E-F9; produced by fusing human lymphoblasts, GM11024, 46,XX,t(X;2) (p21.2;q37), with HPRT-deficient, ouabain-resistant mouse RAG cells; selected in HAT medium; retains human der(X) in 100% of cells & other human chromosomes |
| GM11099 | 100 | der(X)t(X;16)(q26;q24) (100%) | Line CY2; produced by the fusion of human fibro, GM03884, 46,X,t(X;16)(q26; q24), with APRT- & HPRT- deficient mouse A9 cells; selected in alanosine-adenine medium; grown in AAT medium; retains human der(X)t(X;16) in 100% of cells |
| GM11100 | 100 | der(16)t(X;16)(q26;q24) (100%) | Line CY3; produced by the fusion of human fibro, GM03884, 46,X,t(X;16)(q26; q24), with APRT- & HPRT-deficient mouse A9 cells; selected & grown in HAT medium; retains the human der(16)t(X;16) in 100% of cells |
| GM14050 | 100 | der(X)t(X;13)(p22;q12) (100%) & other human chromosomes | Line CF25; produced by the fusion of human fibroblasts, 46,X,t(X;13)(p22;q12), with HPRT-deficient mouse A9 cells; grown in DMEM medium with HAT; retains the der(X)t(X;13) in 100% of cells & other human chromosomes |
| GM10063 | 98 | der(X)t(X;21)(p21;p12) (98%) | Line A2-4; HPRT-deficient mouse A9 cells fused with fibroblasts from a patient, GM10062, t(X;21)(p21;p12), with muscular dystrophy; grown in HAT medium; 98% of cells retain the human der(X) chromosome |
| GM10501 | 97 | der(X)t(X;17)(p11.21;p11.1) (97%) & other human chromosomes | Line 88H-5; produced by PEG fusion of human fibroblasts, GM07151, 46,X,t(X;17) (p11.21;p11.1), with HPRT-deficient Chinese hamster cell line RJK88; selected in HAT medium; retains der(X)t(X;17) in 97% of cells & other human chromos |
| GM10663 | 96 | del(X)(q27) (96%) & other human chromosomes | Line 2384-A2; produced by the PEG fusion of lymphos from a pt with hemophilia B, del(X)(q27), with HPRT-deficient Chinese hamster RJK88 cells; grown in HZ medium; retains human #6 (100%), 11 (96%), 17p(28%), 21 (84%) & del(X) (96% of cells) |
| GM11023 | 96 | der(X)t(X;4)(p21;q35) (96%) & other human chromosomes including an intact chromosome 4 | Line IC-C3; produced by fusing human lymphoblasts, GM11025, 46,XX,t(X;4)(p21; q35), with HPRT-def, ouabain-resistant mouse RAG cells; selected in HAT medium; retains hum der(X)t(X;4) in 96% of cells & other human chromosomes including #4 |
| GM11941 | 96 | | Line 1W1LA4.9; produced by the fusion of human lymphocytes, 46,XY, with HPRT-def mouse L cell line 1R cells; grown in medium without selection; retains human chromosome #11 in 100% of cells & Xp translocated to a mouse chromo in 96% |
| GM14221 | 96 | der(X)t(X;4)(p21;q35) (96%) & other human chromosomes | Line HHW1372; produced by the fusion of hum cells from a female subject with muscular dystrophy with Chinese hamster cells; grown in medium with HAT; retains a human der(X)t(X;4)(p21;q35) in ??% of cells & other human chromosomes |
| GM10095 | 94 | der(9)t(X;9)(q13;q34) (94%) | Line CF11-4/5; produced by the fusion of HPRT-def Chinese hamster cell line CHW 1102 & human lymphocytes from a female with a balanced t(X;9)(q13;q34) using Sendai virus; selected in THAG medium: retains the der(9)t(X;9) in 96% of cells |
| GM10482 | 92 | der(11)t(X;11)(q26;q23) (92%) & 7 (80%) | Line MCH110.1 C4; produced by fusing human fibroblast (GM03552) with a 46,X,t(X;11) (Xpter>Xq26::11q23>11qter;11pter>11q23:: Xq26>Xqter) karyo with mouse line A9 cells; selected in HAT medium: 92% cells have human der(11)t(X;11) and 80% have #7 |
| GM11173 | 92 | der(X)t(X;1)(p21.2;p12) (92%) & other human chromosomes | Line AA-H; produced by fusion of human lymphos from female with DMD, t(X;1) (p21.2;p12), with HPRT-def Chinese hamster RJK88 cells; grown in medium with hypoxanthine & azaserine; retains human der(X) (92% of cells) & other hum chromo |
| GM11750 | 92 | der(X)t(X;3)(p2?;p13) (92%) | Line R1-1; produced by the fusion of human lymphoblasts, der(X)t(X;3)(3pter> 3p13::Xp2?>Xqter), with mouse RAG cells; grown in HAT medium; retains human 3pter>p13 in 92% of cells |
| GM13339 | 88 | der(X)t(X;3)(q28;q21) (88%) & other human chromosomes | Line G1A-10; produced by the fusion of human fibro, GM00194, 46,X,t(X;3)(Xpter> Xq28::3q21>3qter), with mouse A9 cells; grown in HAT medium; retains human der (X)t(X;3) in 88% of cells & #4, 15, & 20 in 36%, 40%, & 8% of cells respectively |
| GM13492 | 88 | der(2)t(X;2)(q13.3;q32.2) (88%) & other human chromosomes | Line HCG10; produced by the fusion of hum lymphos from a Menkes syn pt, 46,X, t(X;2)(q13.3;q32.2) with HPRT-def RJK88 Chinese hamster cells; med contains hypoxanthine & azaserine; 88% of cells retain the der(2)t(X;2) & other hum chromo |
| GM09142 | 86 | | Line C2-T10; HPRT-deficient A9 mouse cells fused with human fibroblasts, t(X;21)(p21;p12); 86% of cells retain the der(21), 100% have human chromosome #3, & 50% of cells have human chromosome #5 |